Yadagiri Pendri
Yadagiri Pendri
Chief Executive Officer, Escientia Life Sciences
Elected to the Academy in 2026

Education

Osmania University, BSc, Chemistry and Genetics; Osmania University, MSc, Organic Chemistry; National Chemical Laboratory, PhD, Synthesis of Biologically Active Compounds; UT Southwestern Medical Center, Postdoc

Professional Areas

Process development expertise in chemical synthesis, specializing in designing and optimizing synthetic pathways for complex APIs. Proficient in retrosynthesis, design of experiments, continuous manufacturing, green chemistry, and process analytical technology, ensuring accelerated development and cost.

Citation

For significant contributions as a process chemist to twenty-four drug candidates across small molecules and Antibody Drug Conjugates (ADC), and for developing large-scale ADC manufacturing methods that are still used today and processes used for the manufacturing of at least three compounds marketed by major pharmaceutical companies.